| http://www.w3.org/ns/prov#value | - We now have robust patent protection for luliconazole in the treatment of onychomycosis through these two new patents along with the issued composition of matter patent and other licensed formulations patents and patent applications, said Greg Vontz, president and chief executive officer of TOPICA. Morrison & Foerster's Palo Alto Intellectual Property Group advised the company on the prosecution
|
